Related Experiment Video
Updated: Jan 22, 2026

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
Published on: August 28, 2018
Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibition: A Lipocrinologic Review
1Endocrnologist, Bharti Hospital, Karnal, Haryana.
Abstract:
This review describes the endocrine impact of proprotein convertase subtilisin kexin 9 (PCSK9) biology and PCSK9 inhibition. It discusses the relationship of the pituitary, thyroid, parathyroid, pancreatic, adrenal and gonadal hormones with lipid health. It also explores the status of PCSK9, and impact of PCSK9 inhibition, in dyslipidemia associated with endocrinopathy. This review should stimulate interest in the lipocrinologic aspects of PCSK9 inhibitors.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Feedback Inhibition
Enzyme Inhibition
Inhibition of Cdk Activity
Ions and Ionic Charges

